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Abstract
Background: Mammalian spermatogenesis involves formation of haploid cells from the male
germline and then a complex morphological transformation to generate motile sperm. Focusing on
meiotic prophase, some tissue-specific transcription factors are known (A-MYB) or suspected
(RFX2) to play important roles in modulating gene expression in pachytene spermatocytes. The
current work was initiated to identify both downstream and upstream regulatory connections for
Rfx2.
Results: Searches of pachytene up-regulated genes identified high affinity RFX binding sites (X
boxes) in promoter regions of several new genes: Adam5, Pdcl2, and Spag6. We confirmed a strong
promoter-region X-box for Alf, a germ cell-specific variant of general transcription factor TFIIA.
Using Alf as an example of a target gene, we showed that its promoter is stimulated by RFX2 in
transfected cells and used ChIP analysis to show that the promoter is occupied by RFX2 in vivo.
Turning to upstream regulation of the Rfx2 promoter, we identified a cluster of three binding sites
(MBS) for the MYB family of transcription factors. Because testis is one of the few sites of A-myb
expression, and because spermatogenesis arrests in pachytene in A-myb knockout mice, the MBS
cluster implicates Rfx2 as an A-myb target. Electrophoretic gel-shift, ChIP, and co-transfection assays
all support a role for these MYB sites in Rfx2 expression. Further, Rfx2 expression was virtually
eliminated in A-myb knockout testes. Immunohistology on testis sections showed that A-MYB
expression is up-regulated only after pachytene spermatocytes have clearly moved away from the
tubule wall, which correlates with onset of RFX2 expression, whereas B-MYB expression, by
contrast, is prevalent only in earlier spermatocytes and spermatogonia.
Conclusion: With an expanding list of likely target genes, RFX2 is potentially an important
transcriptional regulator in pachytene spermatocytes. Rfx2 itself is a good candidate to be regulated
by A-MYB, which is essential for meiotic progression. If Alf is a genuine RFX2 target, then A-myb,
Rfx2, and Alf may form part of a transcriptional network that is vital for completion of meiosis and
preparation for post-meiotic differentiation.

Background
Spermatogenesis encompasses the complex differentiation that converts cells of the male germline into haploid,

motile spermatozoa. It involves three major phases. Spermatogonia derived throughout adult life from the germinal stem cells multiply by mitosis and commit to
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differentiation. Germ cells become spermatocytes as they
enter meiosis, which will generate haploid progeny. The
resultant spermatids then complete the conversion from a
round, immotile cell, to the elongated, free-swimming
sperm. The renewal of the germinal stem cells, the proliferation of differentiating spermatogonia, and the commitment to enter meiosis are controlled by extracellular
signaling molecules provided by somatic cells of the testis
[see [1-3] for recent reviews]. Successful completion of
meiosis depends on androgen stimulation of Sertoli Cells
[[4,5], reviewed in [6]]. While initiation and completion
of meiosis in the testis normally depend on external cues
and perhaps the physiological environment of the tubule,
much of male meiosis is undoubtedly controlled by an
intrinsic genetic program.
Regulatory factor X 2 (RFX2) is an example of a transcription factor (TF) that may be part of such an intrinsic program of spermatocyte differentiation. The RFX family
consists of 5 related proteins (RFX1-5) [reviewed in [710]]. RFX1-4 have conserved DNA binding domains, recognize the same consensus binding site and can generally
form homo and heterodimers with one another via conserved carboxyl-terminal dimerization domains. RFX5,
while sharing the DNA binding domain with the others,
lacks the dimerization domain and is chiefly devoted to
regulation of genes that are part of the class II major histocompatibility complex (MHCII) [9,10]. While elevated
expression of Rfx1-3 in mouse testis was noted over a decade ago [11], and Rfx4 more recently [see references in
[8]], the more recent discovery of an X box motif [12,13]
in the proximal promoter of the histone H1t gene [14,15]
sparked attention to the RFX family in the context of spermatogenesis. While Rfx1-4 are all expressed at high levels
in haploid cells, only Rfx2 is up-regulated in meiotic cells
to generate a full-length, functional protein [16]. Further,
Rfx2 is the family member whose expression is most narrowly confined to testis [17].
In the present work we set out to identify additional RFX2
targets among pachytene-expressed genes, and also to
search the Rfx2 promoter for clues to upstream regulatory
links. We accomplished both goals. In the case of the Rfx2
promoter, we found a cluster of binding sites for the MYB
family of transcription factors. This was of striking interest
because A-myb knockout mice undergo complete spermatogenic arrest at the pachytene stage of spermatogenesis
[18]. The Myb family, identified initially from two oncogenic chicken retroviruses, consists of three proteins in
vertebrates with a conserved and ancient DNA binding
domain [19]. Myb (c-Myb), the cellular source of the oncogene, is most prevalent in bone marrow and is essential
for development of the hematopoietic system [20,21]. Bmyb (Mybl2) is expressed in all proliferating cells [22]. Amyb (Mybl1), is expressed highly in testis, in certain stages
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of B-cell development, the CNS, and is necessary for mammary gland proliferation [18,20,23-26]. Thus A-myb is the
family member with most specific relevance to spermatogenesis both in terms of expression pattern and by the
KO mouse phenotype [18].
In work to be described we have accumulated evidence
that A-myb is indeed a regulator of the Rfx2 promoter. We
have also shown that the germline-specific Alf gene, which
encodes a variant of general transcription factor TFIIA
[27,28], is likely subject to RFX2 control. Taken together,
these results suggest that RFX2 serves as a downstream
amplifier of A-MYB regulation and provide preliminary
support to a model in which A-myb, Rfx2, and Alf may
form connected links in part of the intrinsic spermatogenic control program during meiosis.

Results
Identification of additional RFX2 target genes
Transcription factors are typically used to regulate multiple genes, and it seems likely that more potential RFX2
targets exist among pachytene up-regulated genes than
those presently identified (H1t, Dkkl1, Lmna vC2, and Alf
[12,13,29]). To identify additional targets, we manually
searched for X boxes in promoter regions of genes identified by array screens as showing up-regulation in the testis
between 11 and 14 days of age [30], the period in which
pachytene cells first appear [31]. We identified high quality X box motif matches in promoter regions for phosducin-like 2 (Pdcl2), sperm antigen 6 (Spag6) and a
disintegrin and metalloproteinase 5 (Adam5) (Fig. 1).
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Figure
X
up-regulated
box motifs
1
genes
present in the 5' control region of pachytene
X box motifs present in the 5' control region of pachytene up-regulated genes. Dark shading shows identity to
the perfect inverted repeat at the top. Because of the uncertainty of some transcriptional start sites, the location of
these motifs is given relative to the translational start codon.
The interleukin 5 receptor alpha (IL5RA) sequence [32] is a
relatively strong RFX motif used as labeled probe in binding
assays (location given relative to transcriptional start site).
Sequences are from mouse genes except for human IL5RA
and rat H1t.
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Alf is a potential RFX2 target
Alf is a particularly interesting RFX2 target, because, as a
variant general transcription factor, it has potential to
modulate transcriptional patterns in subsequent phases of
spermatogenesis [28]. Thus Alf is a possible forward link
in the program of differentiation that directs spermatogenesis. To obtain additional evidence for a role of RFX2
in the activation of the Alf promoter, we wanted to show
that co-expression of RFX2 would lead to up-regulation of
an ALF-driven reporter in transfected cells. Transactivation
by RFX2 has not been well studied, but it has substantial
homology with RFX1 between the DNA binding domain
and the carboxyl terminus [11]. RFX1 has a transcriptional
inhibitory domain that overlaps the C-terminal dimerization domain such that deletion of much of the carboxyl
terminus generates a protein with substantially greater
activation activity [34]. In preliminary experiments we
established that full length RFX2 did not transactivate a
simple X-box reporter plasmid (pEP4-luciferase) or a luciferase reporter driven by the Alf promoter in mouse NIH
3T3 cells (results not shown). We therefore generated a
series of deletions running throughout the Rfx2 carboxyl
terminal region. Of these the most active removed amino
acids between 353 and 652, which is similar to one of the
most active Rfx1 deletions described by Katan et al. [34].
This Rfx2 del-353 variant conveyed substantial activation
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Considering this group of pachytene-expressed genes, the
X boxes display a range of variations on the ideal
sequence, which is an inverted repeat of the half site GTTGCC, with a spacer of 0 to 3 nucleotides [32,33]. The
binding affinity of the X boxes may be a guide to the sensitivity of the different promoters to increases in RFX2
expression. We therefore ranked the binding motifs by
competitive EMSA analysis. We first used a specific RFX2
antibody to show that pachytene spermatocyte cell
extracts generated a prominent RFX2 complex with representative oligos (Fig. 2A). From previous experiments, the
major band shifted by the RFX antibody could be assigned
to an RFX2 homodimer [11,13]. This assignment is also
supported by the fact that RFX2 is the only family member
expressed at high levels in spermatocytes [13,16]. As a
result the excess of RFX2 causes nearly all of the less prevalent RFX1 to occur as an RFX1:RFX2 heterodimer, which
migrates more slowly due to the larger size of RFX1[11,13]
(Fig. 2A). The pachytene extract was then used for competition gel shifts with different X box oligos as unlabeled
competitors (representative examples given in Fig. 2B).
The RFX2 homodimer band was quantitated by phosphorimaging and results plotted (Fig. 2C). Binding affinities for the individual sites are clearly determined by their
relatedness to the ideal perfect inverted repeat (Fig. 1). The
three newly identified X boxes (Pdcl2, Spag6, Adam5) are,
along with Alf (Fig. 2A), the strongest binding sites yet
identified in testis-expressed genes.
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Figure 2
Characterization
pachytene-expressed
of Xgenes
box motifs in promoter regions of
Characterization of X box motifs in promoter
regions of pachytene-expressed genes. (A). Examples of
gel shift results using oligos for four different X boxes and a
whole cell extract from pachytene spermatocytes. In each
case one lane shows the super-shift bands resulting from preincubation with a specific RFX2 antibody. The RFX2 heteromer band "ht" is likely formed by an RFX1:RFX2 dimer
[11,13]. The identity of the prominent bottom band "ns",
which is not prevalent in nuclear extracts, is unknown. (B).
Examples of gel shift competition in which the labeled probe
was IL5RA [32], and cold competitor oligos were added to
reactions in amounts from 5 to 50 ng. Spag6 is a strong binding site while Dkkl1 is relatively weak. (C). Quantitative display of the results of gel shift competition. The RFX2
homodimer band was quantitated by phosphorimaging with
results normalized to the bound complex obtained with no
competitor. Points are the average of two independent
experiments. An oligo for the unrelated NFY binding site did
not compete over the same concentration range (not
shown).
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to the X box reporter plasmid (Fig. 3B). Importantly, Rfx2
del-353 also imparted a three-fold activation to a minimal
Alf promoter linked to luciferase (Fig. 3A, C). In order to
show that activation of the Alf promoter depends on the
X-box, we mutated it (Fig. 3A). The construct with a
mutant Alf promoter lost responsiveness to Rfx2 expression (Fig. 3C). This result demonstrates that truncated
RFX2 will activate the Alf promoter via its X box.
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Figure
Alf
promoter
3
is up-regulated by RFX2 expression
Alf promoter is up-regulated by RFX2 expression. (A)
Sequence of the minimal -117 to -5 Alf promoter with the Xbox underlined. Alterations used to make the mutant X-box
are indicated. (B) Demonstration that carboxyl deletion
greatly enhances transactivation potential of RFX2. Transient
transfections, using pEP4-Luc (with 4 repeats of the hepatitis
B virus enhancer X-box) as a reporter, were done plus or
minus expression vectors for full length RFX2 or the d353
construct missing amino acids 353 to 653. (C) RFX2 stimulation of the Alf promoter. Transient transfections were carried out using the minimal Alf promoter or a variant with a
mutant X-box, plus or minus the RFX2 d353 expression vector. Note different scales for the Y axes. (D) ChIP assay
shows in vivo Alf promoter occupancy by RFX2. Left: Amplification of Alf promoter following chromatin capture by antiRFX2 or IgG control. Right: Amplification of unrelated Tcrd
(T cell receptor delta) gene following chromatin capture.

If RFX2 is indeed a transcriptional modulator of the Alf
gene, then it should be bound to the Alf promoter in vivo.
We next carried out ChIP assays to verify this prediction
(Fig. 3D). Immuno enrichment for chromatin fragments
carrying RFX2 led to selective recovery of the Alf promoter
region, whereas no selective recovery was found for an
irrelevant DNA region of the Tcrd gene (Fig. 3D). This
result confirms that RFX2 is part of the Alf promoter
ensemble during spermatogenesis.
The Rfx2 promoter
With a number of plausible RFX2 target genes identified,
we turned our attention to the transcriptional control of
Rfx2 itself. Our hope was to link Rfx2 up-regulation in
pachytene cells to a specific factor or factors that control
an upstream step in spermatogenic differentiation. The
immediate 5'-region of the mouse Rfx2 gene lies in an 0.5
kb sequence that fits the criteria of a CpG island [35] (Fig.
4A). It lacks a TATA box and, based on the recovery of 5'RACE clones distributed over a 120-bp region (Fig. 4A)
[16], has a dispersed rather than a focused transcriptional
start site [36]. Inspection of this region with a web-based
search protocol [37] identified potential binding sites for
a number of common transcription factors. A cluster of
sites about 200 bp upstream of the assigned database cap
site was striking (Fig. 4A). This includes two perfect GC
boxes for SP1/3 in addition to multiple imperfect GC
boxes typical of a CpG island. A perfect CAAT box lies
slightly farther upstream and is an excellent match to the
extended consensus binding site for NFY [38]. Of special
note is a complex of three RFX half sites, suggesting an element of auto-regulation. Finally, the presence of three
sequences with perfect matches to the MYB binding site
(MBS) consensus (YAACG/TG) [39] was particularly relevant considering that mice with a homozygous null allele
for A-myb display spermatogenic arrest at pachytene [18].
MBS-1 (Fig. 4B), nearest the transcriptional start, is unusual by being repeated on the complementary strand with
a 3 bp displacement, thus forming a partially overlapping
pair of inverted sites. MBS-1 is rendered even more complex because it also lies within the two upstream Rfx half
sites. This tight cluster of MBSs immediately suggested
that they might impart A-MYB regulation to Rfx2. Our
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Features
Figure 4of the 5' regulatory region of the mouse Rfx2 gene
Features of the 5' regulatory region of the mouse Rfx2 gene. (A). Nucleotide sequence with +1 based on [NCBI RefSeq:NM_009056]. Solid circles above nucleotides designate additional transcriptional start sites identified by 5'-RACE cloning
[16]. Exon 2 is shown until the translational start. MYB binding sites (MBS) are indicated by tan shading. An NFY motif is indicated by blue shading. Perfect 9-nt GC boxes are shaded yellow. RFX half sites are boxed without shading. (B). The three Rfx2
MBSs are compared to the consensus and to the unusually strong chicken mim-1-A site. The sites are numbered starting closest to the transcriptional start site and shown as the A-rich strand, regardless of the actual orientation. MBS1 consists of partially overlapping sequences in opposite orientations designated 1A and 1B. (C). Diagram of the promoter region showing
locations of factor binding sites. M, MBS; Sp, GC box; X, RFX half site. Amplified promoter fragments used in reporter vectors
are indicated below (PFA, -274 to +24; PFB -274 to -132; PFC, -224 to -157).

consideration of this possibility was reinforced by the fact
that the three MYB sites, along with most of the others
mentioned above, are well conserved among a variety of
mammals [40]. (Interestingly, although not a subject of
this report, strong sequence conservation continues
through much of the remaining downstream promoter as
well as throughout the non-coding 1st exon.)
The role of MYB binding sites in the Rrx2 promoter
Our first step in examining the possible functional role of
these motifs was to test them for MYB binding affinity.
The three cellular MYB proteins share a conserved amino
terminal tripartite DNA binding domain and recognize
the same sequence motif [19,20]. One of the complexities
of the Myb family is the presence of a carboxyl inhibitory
domain [41-43], which inhibits DNA binding as well as
transcriptional activation [44,45], particularly for A-myb
[45]. For binding studies we therefore used a bacterially

expressed fusion protein containing amino acids 1-194 of
A-myb. Oligos were prepared for the Rfx2 MBS-1 and MBS3 sites as well as the chicken mim-1 MBS A site [46,47],
which is an unusually strong MBS. Preliminary mobility
shift experiments established that each of the motifs from
Rfx2 binds specifically to the fusion protein but that none
is as strong as the mim-1 site, which depends on the AT
run at its downstream side for its unusual character [47].
To compare these sites side-by-side we performed a competition assay in which the Rfx2 MBS-1 oligo was radioactively labeled and the different MBS oligos were used as
unlabeled competitors (Fig. 5A). Both Rfx2 MBS-1 and
MBS-3 were comparable as competitors, while the Mim-1A site was clearly stronger. A control oligo with a perfect
GC box failed to compete at the concentrations tested. In
other experiments we showed that the MBS-2 site has a
binding affinity comparable to MBS-1 and -3 (results not
shown).
Page 5 of 15
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Figure 5 characterization of Rfx2 MBS sites
Functional
Functional characterization of Rfx2 MBS sites. (A). Binding competition for Rfx2 MBS by gel mobility shift assay. The
MBS1 oligo was used as labeled probe for the bacterially expressed A-MYB DNA binding domain-maltose binding fusion protein. Lanes show increasing amounts of unlabeled competitor oligonucleotides in the range of 50 to 500 ng. (B). Stimulation of
Rfx2 promoter fragments by co-transfection of A-myb expression vector. Transient transfections were carried out with or
without the C-terminal truncated A-myb expression vector. The locations of the promoter fragments are indicated in Fig. 4C.
Note that the scale for PFB and PFC is amplified 2-fold. (C). Ability of individual Rfx2 MBS multimers to promote expression of
a luciferase reporter. Individual MBSs were ligated in a head to tail fashion to generate 5 copies in a minimal promoter luciferase vector. Results are of transient transfection plus or minus co-transfection with the A-myb d304 expression plasmid. Fold
activation is indicated above the (+) columns. (D). ChIP assay shows in vivo Rfx2 promoter occupancy by A-MYB. Left: Amplification of Rfx2 promoter following chromatin capture by anti-A-MYB or IgG control. Right: Amplification of unrelated Tcrd
locus following chromatin capture.

We next asked whether the cluster of MBSs would impart
MYB responsiveness to the Rfx2 promoter in co-transfection experiments. A promoter fragment from -274 to +24
(PFA, Fig. 4C) was cloned into the pGL3 Luciferase
reporter. Two subfragments of the promoter containing
either just the cluster of MBSs or an extended fragment
(PFC and PFB, Fig. 4C) were cloned into pPoly(A)-EW5E1B-Luc. Preliminary experiments using an expression

vector for full length A-myb indicated that no stimulation
was imparted to the Rfx2 PFA region over a range of plasmid DNA concentrations. Removal of the carboxyl inhibitory domain generates a protein with greater activation
potential that is less dependent on the promoter-cell line
combination used. Using a C-terminal truncated version
of A-myb, we established that PolyA-EW5-E1B-Luc [47],
which contains 5 mim-1-A sites joined head to tail
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Rfx2 expression in A-myb KO mice
If Rfx2 expression is dependent on A-myb, then Rfx2
should be dramatically diminished in testes from A-myb
knockout mice. Tissues from A-myb KO mice and wildtype (wt) littermates were kindly made available to us by
E. P. Reddy. We examined Rfx expression, first by western
blotting of total protein extracts prepared from knockout
mice and their normal littermates. The prominent testis
RFX2 band identified in wt testes was nearly undetectable
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We then carried out ChIP assays to test whether A-MYB is
associated with the Rfx2 promoter in vivo in testis germ
cells (Fig 5D). An A-MYB-specific antibody selectively
enriched for Rfx2 promoter sequences from mixed germ
cells, a result not obtained for a control sequence in the
irrelevant Tcrd locus. Thus ChIP confirmed that A-MYB is
indeed found on the Rfx2 promoter in vivo.
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We then tested each MBS individually by ligating 5 copies
in a head to tail fashion into pPolyA-EW5-E1B-Luc from
which the mim-1 MBS sequences had been excised. While
fold activations varied widely (based largely on the background activity of each plasmid), both MBS-1 and -3
imparted an A-myb-stimulated activity equal or greater
than that of the widely used mim-1 sequence (Fig. 5C).
MBS-3 generated the greatest and MBS-2 the least absolute
stimulation. It is possible that differences in transcriptional activation by the individual concatenated sites were
due in part to accidental creation of binding motifs
through the ligation sites. This remains to be investigated.
Taken together, the results described thus far show that
the three putative MBS sites have comparable MYB-binding activity and that they can convey transcriptional activation, either as concatenated 5-mers or when present as
a mixed cluster within the Rfx2 promoter.
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upstream of the adeno E1B core promoter, responded in a
dose-dependent manner to co-transfection with the truncated A-myb expression vector in NIH 3T3 fibroblasts
(results not shown). Experiments then showed that the
longest Rfx2 promoter fragment (PFA) was stimulated 3fold by co-transfection with truncated A-myb (Fig. 5B).
This effect is specific since the A-myb expression vector had
no significant effect on the TK-driven Renilla luciferase
gene used as an internal control in transfection experiments. With the promoter subfragments PFB and PFC,
this stimulation increased to the 10 to 15 fold range,
although the absolute magnitude of stimulation was less
(Fig. 5B). Somewhat surprisingly, the absolute activity was
comparable regardless of whether the adjacent CAAT and
GC elements were present (PFB) or not (PFC) (Fig. 5B).
These results demonstrate that an A-myb expression vector
conveys stimulation to the natural promoter of the Rfx2
gene and that stimulation is retained by subfragments
centered on the three MBSs.
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Figure
Gene expression
6
in A-myb null mice
Gene expression in A-myb null mice. (A). Western blot
of three organs from wild type CD-1 mice and from testes of
129/Jx C57BL/6 A-myb null and wt littermates. Top, anti
RFX2. Bottom, anti SP1. (B). Determination of mRNA for
Rfx1-4 in testes of A-myb null and wt littermates by quantitative real-time PCR. (C). Determination of mRNAs for reference genes c-Kit, H1t, and Ldhc in testes of A-myb null and wt
littermates by quantitative real-time PCR.
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in the testes of A-myb KO mice (Fig. 6A). We used the transcription factor SP1 as a control as its expression is highest
in non-germinal cells and in early germ cells [48]. Its level
was not reduced in the KO testes. Extracts from liver and
kidney, which do not express significant Rfx2 [11], served
as controls to demonstrate the antibody specificity. Rfx14 have different patterns of expression during spermatogenesis [16], and we determined the transcript levels of
each in the KO mice using quantitative real-time PCR (Fig.
6B). Expression of all family members was reduced in the
KO mice, with the greatest changes seen for Rfx2 and Rx4.
Rfx4 expression in testis occurs only from downstream
promoters activated in spermatocytes and spermatids
[8,16], and the virtual absence of Rfx4 transcripts agrees
with the absence of cells beyond early pachytene. Rfx2
transcripts were decreased to less than one percent of wild
type animals. As reference genes with known expression
patterns, we also examined c-Kit, H1t and Ldhc by realtime PCR (Fig. 6C). c-Kit, which is expressed in differentiated spermatogonia [3], was elevated in KO testes, likely
because the KO testes are relatively enriched for these cells
compared to wild type. H1t, which is expressed at a low
level in early spermatocytes, but primarily in mid to late
pachytene cells, was reduced to 3% of wt. Ldhc, which is
expressed prior to pachytene at low levels but significantly
upregulated in pachytene [49], was reduced to essentially
undetectable levels. These results confirm that spermatogenesis is arrested in A-myb KO mice during meiosis
and, in particular, document that Rfx2 expression is strikingly reduced.
Contrast of A- and B-myb expression during
spermatogenesis
Expression of A-myb and B-myb in mouse testis has been
investigated at the mRNA level by several techniques
[23,24,26]. These studies showed that B-myb expression is
restricted to early germ cells, likely to be spermatogonia,
but that A-myb expression, in contrast, peaked in meiotic
cells. Since expression of these proteins in the testis has
not been studied at the level of immunohistology, we
thought it worthwhile to investigate their expression patterns in histological cross sections of mouse testis. B-MYB
(Fig. 7A-D) was located exclusively in the outermost germ
cell layer lying next to the peritubular cells that define the
outer perimeter of seminiferous tubules. The histological
patterns of germ cell associations seen in different tubules
define 12 stages of the cycle of the seminiferous epithelium [50,51], and both spermatogonia and meiotic cells
up to early pachytene are found in the outermost layer.
Regardless of the stage of the cycle, the only cells with
bright nuclear fluorescence lay within the outermost germ
layer. The majority of these were in pre-leptotene to early
pachytene. Some spermatogonia were likely identified as
well though these cells are more difficult to identify by the
fixation and staining procedures employed. Immune
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immunofluorescence
Location
Figure
7of A-MYB and B-MYB expression in mouse testis by
Location of A-MYB and B-MYB expression in mouse
testis by immunofluorescence. (A-D). Green, B-MYB,
pseudocolor red, DAPI). (A). Tubule of approximately Stage
VI, in which B-spermatogonia (B) or early spermatocytes are
the most B-MYB positive cells in the outer most germ cell
layer. Nuclei of pachytene cells (P) are faintly positive. (B)
Tubule of approximately Stage VIII. Leptotene spermatocytes
(L) are strongly B-MYB positive, while mid-late pachytene
spermatocytes (P) are unreactive. (C). Tubule of approximately stage X. Leptotene-zygotene spermatocytes (L-Z) are
strongly B-MYB positive, while late pachytene spermatocytes
(lP) are unstained. (D). Tubule of approximately stage I. Early
pachytene spermatocytes (eP) remain positive for B-MYB.
Spermatids are uniformly negative in these tubules. (E-G). AMYB. (E). Tubule of approximately stage I. Nuclei of early
round spermatids are A-MYB positive (arrowhead), while
early pachytene spermatocytes and other cells in the outermost germ cell layer are uniformly negative. (F). Tubule of
approximately stage VIII. Nuclei of late pachytene spermatocytes (lP) are positive while reaction of late round spermatid
nuclei is reduced (arrowhead). (G). Tubule of stage XII.
Nuclei of diplotene spermatocytes (D) and the condensed
chromosomes of the metaphase of meiosis I (M) are A-MYB
positive. Note that cells in the outermost germ cell layer
(spermatogonia and early spermatocytes) are uniformly negative in all tubules.

Page 8 of 15
(page number not for citation purposes)

BMC Developmental Biology 2009, 9:63

http://www.biomedcentral.com/1471-213X/9/63

detection was rapidly lost as early pachytene spermatocytes moved away from the peritubular cells and entered
the mid-pachytene phase of meiosis. In contrast, immunoreactivity for A-MYB identified essentially a completely
different population of germ cell nuclei (Fig. 7E-G). Spermatogonia and early spermatocytes in the outermost
germ cell layer were not A-MYB positive, but meiotic
nuclei of mid-pachytene and later were readily labeled
(Fig. 7E). Immunoreactivity was retained in early round
haploid cells (spermatids) seen in Fig. 7D. Immunoreactivity was significantly less in late round spermatids just
about to undergo nuclear elongation (Fig. 7F). Condensed spermatid nuclei near the center of the tubules did
not react with anti A-MYB (Fig. 7G, E, F). Sertoli cell
nuclei, which are largely found at the periphery of the
tubules, did not react with the antibody. These results confirm that there is a marked difference in the expression of
these two MYB factors and that little overlap occurs as
detected by immunofluorescence.
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As a final approach to confirm the cell-type distribution of
A- and B-myb, we applied quantitative real-time PCR to
estimate mRNA levels during development of the first
cohorts of spermatogenic cells in young mice (Fig. 8).
Because the first wave of development is relatively synchronous and well characterized, we could correlate the
progression of the most advanced cells with the age of the
animals [31]. B-myb mRNA remained essentially constant

5I[

Figure 8by quantitative
Determination
opment
of mRNA
real-time
expression
PCRin testes during develDetermination of mRNA expression in testes during
development by quantitative real-time PCR. RNA levels for A-myb and B-myb are compared with those of Rfx2.

from 8 days, when the most advanced cells are differentiated A and B spermatogonia, through to adulthood, when
the most prevalent cells are spermatocytes and spermatids. In contrast, levels of A-myb transcripts rose continuously throughout development, indicating that maturing
germ cells contribute significantly to the A-myb transcript
pool. We also determined Rfx2 transcripts, and in view of
our proposed functional connection between A-myb and
Rfx2, it is interesting to note that Rfx2 expression is similar
to but lags slightly behind that of A-myb. (Fig. 8).

Discussion
The work presented serves to direct attention toward a
possible functional connection between the transcriptional regulators A-myb, Rfx2, and Alf. Each is expressed in
a tissue-restricted manner but is particularly prominent in
the male germ line beginning during the pachytene period
of meiotic prophase I. A complex process of cellular differentiation such as spermatogenesis must involve progressive changes in structural and enzymatic proteins but also
in regulatory proteins such as transcription factors. A-MYB
is clearly an essential gene regulator in pachytene [18].
However, its essential target genes have not been determined. In view of the results presented here we propose
that A-myb signaling is broadened and extended by Rfx2,
which is assumed to act both on genes for structural proteins used during spermatogenesis (H1t, Lama vC2) and
proteins actually present in sperm (Spag6, Adam5), but
also on genes such as Alf, that are likely to promote yet further changes in gene expression. While there are other RFX
factors expressed in male germ cells, RFX2 is the only one
that is significantly elevated in pachytene cells [13,16] and
is thus the most likely to effect new gene expression at this
point. These connections remain tentative because they
are based primarily on correlations due to the difficulty of
manipulating gene function directly in the testis.
In the first part of this work we identified three new potential RFX2 target genes that are sharply up-regulated during
pachytene, a point in meiosis at which the fundamental
events of chromosome pairing and the initiation of
recombination events have already occurred, and early
expression of genes that will eventually generate the distinctive features of a sperm has begun. Pdcl2 encodes a
protein related to phosducin, a heterotrimeric G-protein
modulator in the retina [52]. By reference to the role of
the ortholog in yeast, Pdcl2 is likely important for formation of haploid cells, although its exact function is not yet
understood [53]. Spag6 encodes a protein that functions
as part of the central axoneme of the sperm flagellum.
Knockouts for Spag6 are infertile due to motility and morphological defects but also have severe hydrocephaly,
apparently reflecting ciliary defects in brain ependymal
cells [54] (perhaps indicating roles of other RFX factors in
the CNS [8]). ADAM5 is part of a large family of trans-
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membrane proteins that can serve as integrin ligands.
While it is detected in the embryonic prospermatogonia
[55], it is also expressed during spermatogenesis and
appears on the mature sperm surface after undergoing
proteolytic processing in the epididymis [56]. These three
genes have X box motifs with strong binding affinities and
each shows marked up-regulation in developing testes at
a point coincident with early entry into pachytene [30].
Interestingly, H1t, perhaps the first spermatogenic gene
identified with an X box-containing promoter [12,13],
has a low affinity X box, which may account in part for the
delayed appearance of H1t in mid/late pachytene [14,15].
Convincing support for the role of RFX2 in regulating
these genes will require a combination of analysis of targeted X box mutations in transgenic mice as well as the
targeted elimination or knockdown of Rfx2. However, it
would be surprising if the 12 bp long X box motif was
found by chance in the promoter regions of all of these
genes.
Alf is a variant of general transcription factor IIA that is
expressed both in oocytes and spermatocytes, and is a
member of a small family of variant forms of core promoter factors that is often restricted to or expressed maximally in the gonads [28,57]. In some cases, such as TRF2,
a variant of TATA box binding protein (TBP), or of TAF4b,
a TATA box associated factor variant, mice with targeted
null mutations undergo arrested spermatogenesis, documenting the critical importance of these general TF variants [58-60]. In the case of Alf, results for a knockout
mouse are not available, but, in view of the important role
of these other general TF variants, it is prudent to consider
that it imparts selectivity to gene expression in pachytene
or later. Kim et al. [29] first noted that the Alf promoter
region contains a strong X box motif and showed that an
EMSA band obtained with a promoter fragment and a
liver extract was eliminated by an RFX1 antibody. We have
extended these observations and shown that the minimal
Alf promoter is responsive through its X box in transfected
cells to co-expression of truncated RFX2. Further, we
showed by ChIP analysis that the Alf promoter is occupied
by RFX2 in testis germ cells. For these reasons we speculate
that Alf is a genuine RFX2 target. As an incidental aspect of
this study, we showed for the first time that RFX2, like
RFX1 [34] has an auto-regulatory carboxyl terminal
domain that inhibits transcriptional activation (though
not DNA binding). Thus deletion of most of the carboxyl
terminus generated a form of the RFX2 with greatly
enhanced transcriptional activation on either a reporter
with multimerized X boxes or one driven by the Alf promoter. The need to use a truncated form of RFX2 to
achieve transactivation presumably indicates that NIH
3T3 cells lack important tissue-specific factors that would
normally neutralize the RFX2 inhibitory domains.
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In discussion of the role of X box motifs, it should be
pointed out that X box motifs are prevalent within conserved noncoding sequence elements in the human
genome [61]. The significance of this observation is
unknown, but these conserved regions were not confined
to promoters. Of more relevance here, a functional
genomics analysis of transcription factor binding sites that
are over-represented in the immediate promoters of tissue-enriched/specific genes identified the X box motif
only within the testis set [62]. Our focus here is on the
pachytene phase of meiosis, but there may well be additional genes controlled by RFX factors in the haploid
phase of spermatogenesis.
Changing our attention to possible upstream regulation
of the Rfx2 gene, we identified strong binding motifs in
the Rfx2 promoter for a number of transcription factors.
Of interest is the fact that a set of X box half sites occurs as
part of the larger cluster of sites. The RFX family is unusual
in that at least some members, though functionally dimers, can bind to half sites [11]. In the Rfx2 promoter the
downstream pair of half sites occurs in the classic inverted
arrangement, whereas the remaining upstream half site is
either a singleton or might be considered a reversed inversion (Fig. 4A, C). We have shown that indeed this region
will bind RFX2 in pachytene extracts (unpublished) but
have not investigated the roles of the individual half sites.
These sites suggest that some form of auto regulation may
occur for Rfx2, but do not indicate whether it is positive or
negative. In this regard it is interesting that RFX1 has been
shown to repress its own promoter through a pair of relatively distant half sites [63].
In light of the finding that A-myb knockout mice undergo
spermatogenic arrest in pachytene [18], the most dramatic
feature of the Rfx2 promoter to us was the set of three MYB
binding sites with excellent matches to the established
consensus. A-MYB, though similar to both MYB and BMYB, has a distinctly different expression pattern and generates a completely distinct phenotype when eliminated
thorough targeted mutation [18,21,22]. In particular, Amyb is the only Myb member with high level expression in
developing male germ cells beyond the early proliferative
phase. We have confirmed by immunohistochemistry the
generally different expression of B- and A-MYB reported in
the literature, but observed somewhat finer differences
than could be detected by the in situ hybridization techniques used in the past. While B-MYB was expressed
strongly up to the early pachytene stage of meiosis, A-MYB
was expressed strongly only as B-MYB disappeared, in
spermatocytes passing from early to middle pachytene.
Morphologically this corresponds to the point at which
the spermatocytes are clearly moving away from their initial residence along the wall of the seminiferous tubule.
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Accordingly, A-MYB is expressed in the testis in cells that
have completed their final S-phase, attained the point in
meiosis in which chromosomes are fully synapsed and
early recombination events have occurred, and the future
sperm are beginning to take on aspects of their terminal
differentiation.
We showed that each of the three MYB motifs functioned
as a binding site in vitro and also that multimers of each
would convey Myb-dependent activation to a reporter
gene. Further, both the whole Rfx2 promoter as well as a
small segment containing the three MBSs were A-myb
responsive. ChIP also confirmed that A-MYB is bound to
the promoter in vivo. Finally, in testes from A-myb KO
mice, the levels of RFX2 as well as Rfx2 mRNA were greatly
reduced. In view of the fact that many established Myb target genes contain multiple promoter MBSs [21], our
results are entirely consistent with a model in which AMYB is a direct transcriptional activator of Rfx2.
A complexity of both RFX2 and A-MYB is that these transcription factors are characterized by auto-regulation. In
both cases carboxyl terminal domains inhibit amino terminal transactivation domains [34,41-44]. In the case of
A-MYB, this effect extends to marked inhibition of DNA
binding activity [45], meaning that it would be difficult to
identify in nuclear extracts by the usual EMSA procedures.
This is a relatively unusual property of a transcription factor, but has, for example, been well characterized for ETS1
and some of its relatives [64]. Presumably a reason for
such autoregulation is to make individual factors dependent on the particular mix of other DNA binding factors or
co-regulators present, so as to minimize functional consequences from binding to random genomic sites. Unfortunately the lack of cell lines that retain an ability to
undergo meiosis in vitro hampers the study of spermatogenic transcription factors in their home environment.
In fact full understanding of factors or modifications that
render either RFX or MYB proteins functional on genuine
target promoters is very incomplete, except for the elegantly worked out but specialized case of RFX5 [9,10].
That individual Myb factors do have specific in vivo targets is evident from the effects of knockout mice, but has
also been shown dramatically by gene array screens following over expression of individual factors by the Ness
laboratory [65-67]. Some progress has been made in identifying cellular mechanisms for overcoming autoregulation in the case of MYB proteins. Thus, Dash et al. [68]
have shown that the amino and carboxyl ends of MYB
self-associate to bring about silencing, and that p100
(SND1) [69] can overcome this negative auto-regulation.
However, p100 is widely expressed and may not be the
explanation for the promoter-specific effects of MYB. Similarly, it is well known that transcription factor ETS-2 can
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promote the transcriptional activity of both MYB and AMYB [43]. A 110 kDa protein was identified that binds to
A-MYB [70]. Its presence was correlated with the transcriptional activity of A-MYB in B Cell lines and its absence
with lack of A-MYB activity in T cell lines [70]. Unfortunately this 110 kDa protein has not been further characterized. It is not surprising that A-MYB is also subject to
activating [71] and inhibitory [72] phosphorylations that
can play tissue-specific roles. Clearly considerable work
remains to be done to understand why A- and B-MYB
seem to have such different roles during spermatogenesis
and what the complete roll of RFX2 may be. The present
study reports observations that suggest the A-myb - Rfx2 Alf connection could be an important part of the final picture.

Conclusion
The RFX family of transcription factors is broadly up-regulated in post-meiotic cells, whereas RFX2 alone is up-regulated during the later phases of meiosis. This suggests
that RFX2 modulates gene expression during pachytene,
and we have identified three additional pachyteneexpressed genes with X-box-containing promoters. Several
experiments implicated the promoter of variant general
transcription factor Alf as an RFX2 target. We also determined that Rfx2 is itself likely subject to transcriptional
regulation by A-MYB, which is essential for completion of
meiosis in mice. Putting these several observations
together, we hypothesize that RFX2, and its downstream
targets, such as Alf, are part of a transcriptional control
program that depends on A-MYB. More remains to be
done to establish this conjecture, but it does provide a
framework to ask testable questions.

Methods
Mice
Hsd:ICR outbred mice were obtained from Harlan
Sprague Dawley (Indianapolis, IN USA). The use and care
of animals were approved by the University of South
Carolina Animal Care and Use Committee.
Preparation of Purified Germ Cells
Preparation of mid to late pachytene spermatocytes of
about 85% purity from adult mice by elutriation has been
described [73]. Enriched mixed germ cells used for ChIP
consisted of the cell suspension that would be used for
elutriation.
Mobility Shift and ChIP Assays
Whole cell extracts were prepared as described [74] from
pachytene spermatocytes pooled from five elutriator runs.
Oligonucleotides used for probes (See Additional file 1for
sequences.) were obtained from IDT (Coralville, IA, USA)
using 5'-GATC overhangs at either end to facilitate labeling double-strand oligos by Klenow DNA polymerase
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and α- [32P]-dATP (Amersham Bioscience, Piscatawy, NJ).
Reactions contained 10 mM Tris-HCl, pH 7.5, 50 mM
NaCl, 1 mM MgCl2, 0.5 mM DTT, 4% glycerol, and
50,000 cpm of probe and were analyzed as described [75].
When present, unlabeled oligos were added to the reaction mixtures prior to addition of the protein extract.
Radioactive bands from dried gels were quantitated using
a Molecular Dynamics Storm phosphorimager. ChIP
assays were carried out using mixed enriched germ cells
and a Chip-it Express Kit from Active Motif (Carlsbad, CA,
USA), following the instructions provided. Anti A-MYB
(H-125) and anti RFX2 (C-15) were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). See Additional file 1
for primer sequences. PCR reactions were run for 32-33
cycles, and gels were stained with Syto-60 (Invitrogen
Molecular Probes, Eugene OR, USA) and scanned using a
LI-COR Odyssey infrared scanner.
Preparation of plasmid constructs
A mammalian expression vector for a truncated version of
mouse RFX2 that lacks the inhibitory domain (del AA 353
to 653) was constructed by PCR from a cDNA clone
(MGC-6105, ATCC, Manassas, VA, USA) and inserted into
pCI (Promega, Madison, WI, USA). pEP4-luciferase,
obtained from Y. Shaul, contains four copies of the hepatitis B enhancer X box upstream of the adenovirus E1B
TATA box and luciferase reporter [34]. The Rfx2 promoter
region (PFA) was amplified from mouse genomic DNA by
PCR and inserted into pGL3 (Promega). Sub-fragments
lacking the transcriptional start site (PFB, PFC) were likewise generated by PCR from PFA, and exchanged for the
mim 1 MBS 5-mer in pPoly(A)-EW5-E1B-Luc [76]. Pfu
polymerase (Stratagene, La Jolla, CA, USA) was used in
PCR reactions for all constructs. PCR was used to insert
the coding region for human A-Myb AA 1-194 from
expression vector pSG5-A-Myb [77] (obtained from D.
Vercelli) into pMAL-c2X (New England Biolabs, Medford,
MA, USA) to generate a bacterially expressed fusion protein containing the A-Myb DNA binding domain. The
fusion protein was isolated by affinity chromatography as
described by the vector supplier. A mammalian expression vector for A-Myb DNA binding and transactivation
domains was made using PCR to insert the code for AA 1304 into pCI. Head to tail 5-mers of Rfx2 MBSs were generated by ligating oligos with upstream XhoI and downstream SalI overhangs [78] and inserted into pPoly(A)EW5-E1B-Luc after excision of the mim-1 MBS 5-mer. The
minimal Alf promoter was amplified from mouse DNA by
PCR and inserted into pGL3 (Promega). Mutation of the
Alf X box was done by overlap PCR. Details of the construction of these plasmids and primer sequences are
available upon request. Constructs were verified by
sequencing.
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Quantitative Real-Time PCR
Real-time PCR was carried out in an iCycler (Bio-Rad,
Richmond, CA, USA) using a SYBR Green real-time master
mix (Bio-Rad) by procedures described previously (48).
Primer pairs were selected using the Primer 3 program
[79] or a program at the IDT web site. See Additional file
1for sequences. Individual mRNAs were normalized to
18S rRNA by differences in cycle thresholds (Ct) [80] and
results expressed as copies per 106 18S rRNA copies.
Transfections
NIH 3T3 cells were maintained in Dulbecco's modified
Eagle medium (Life Sciences Technologies, Grand Island,
NY) with 10% (v/v) calf serum in a humidified atmosphere of 5% CO2. Cells were seeded into 12-well plates
(100, 000 cells/well) and transfected 24 h later with 6 μg
of TransFast reagent (Promega) and 2 μg of reporter plasmid DNA per well. The thymidine kinase driven Renilla
luciferase (pRL-TK, 100 ng) was cotransfected as a control.
Individual experiments consisted of two or three replicate
wells, with each experiment repeated a minimum of three
times. Rfx2 or A-myb expression plasmids (100 ng) were
cotransfected when indicted. Cells were harvested 48 hrs
after transfection in passive lysis buffer (Promega) and
assayed by the Promega the Dual-Luciferase Assay using a
Turner luminometer. Results are reported as the ratio
between the two luciferase activities.
Western Blot Analysis
Extract preparation, electrophoresis in 8% gels, blotting
conditions, and antibody incubations and detection have
been described previously [48]. The anti RFX2 was Santa
Cruz C-15 and anti SP1 was Santa Cruz H-225.
Immunohistology
Testes were fixed in fresh 4% paraformaldehyde in PBS
overnight, embedded and sectioned by standard procedures. Following paraffin removal in zylene and rehydration, sections were blocked by 3% BSA in PBS, 10%
normal donkey serum (Jackson Immuno Research, West
Grove, PA, USA), and 0.05% Triton X100. Primary antibodies (4 ug/ml, Santa Cruz H-125 A-MYB or H-115 BMYB) were added to the blocking buffer and sections
incubated in a humidified chamber overnight at 4C. After
three 10 min washes in PBS, 0.1% Triton, an Alexa Green
488 conjugated 2nd antibody (Invitrogen) was applied
(1:200 in the blocking mixture) for 2 hr at room temp.
After washing as above, sections were mounted in
Vectashield, 1 ug/ml DAPI and examined with an Olympus microscope. Images were recorded with a DP71 digital camera with the DAPI signal placed in the red channel
using Adobe Photoshop software.
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